Phenazone is an analgesic, antipyretic and anti-inflammatory drug. While it predates the term, it is often classified as a nonsteroidal anti-inflammatory drug. Chemically it is a pyrazolone derivative, commonly known by the synonym antipyrine, with a compact aromatic-pyrazolone structure that confers central nervous system activity. The compound is used in formulations for short term relief of mild to moderate pain and fever and exhibits weak peripheral anti-inflammatory effects. It is absorbed after oral administration and undergoes hepatic metabolism principally by N-demethylation and conjugation pathways. Typical physicochemical properties used in formulation and quality control include a crystalline appearance, moderate aqueous solubility with greater solubility in polar organic solvents and thermal stability suitable for standard solid dosage processing.
Manufacturing and quality control of phenazone monitor specific related substances and generic impurity limits in line with ICH impurity management principles. Typical specification limits used by manufacturers and pharmacopeial monographs set individual related compound limits at or below 0.2 percent and total related substances at or below 1.0 percent on a mass by mass basis, with lower reporting and identification thresholds applied during development. Known related compounds and metabolites that are controlled include 4-aminoantipyrine and 4-acetylaminoantipyrine, each commonly limited to not more than 0.2 percent, together with routine control for residual solvents, heavy metal traces and any aniline type impurities at technically justified limits. Analytical methods used for release and stability testing include HPLC with validated specificity, MS or PDA detection for identification, and limit tests for inorganic and solvent residues.
Phenazone is used for short term symptomatic relief of pain and fever and for mild inflammatory conditions where central analgesic and antipyretic action is appropriate.
Phenazone is often classified as a nonsteroidal anti-inflammatory drug because it has analgesic and antipyretic activity and some anti-inflammatory effect, although it was developed before the modern NSAID class was defined.
Another name for phenazone is antipyrine.
Phenazone exerts analgesic and antipyretic effects primarily through central inhibition of prostaglandin synthesis and modulation of central pain pathways, complemented by weak peripheral anti-inflammatory activity; hepatic metabolism produces demethylated and conjugated metabolites.
